FIELD: medicine; immunology; cardiology and endocrinology.
SUBSTANCE: invention can be used to diagnose metainflammation in patients with coronary heart disease and type 2 diabetes mellitus. The relative content of CD4+CD25lowFoxP3+ T-regulatory lymphocytes from all CD4+ lymphocytes of peripheral blood is determined. Based on the absolute content of lymphocytes obtained during a general blood test, the absolute content of CD4+CD25lowFoxP3+ T-regulatory lymphocytes in the peripheral blood is calculated. With a total absolute content of CD4+CD25lowFoxP3+ T-regulatory lymphocytes in peripheral blood 1.39×107 cells/l or more metainflammation is diagnosed.
EFFECT: method provides diagnostics of metainflammation in patients with coronary heart disease and type 2 diabetes mellitus by determining the total absolute content of CD4+CD25lowFoxP3+ T-regulatory lymphocytes 1.39×107 cells/l or more in peripheral blood.
1 cl, 1 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR DISPOSITION TO ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASES BY PERIPHERAL BLOOD INTERLEUKIN-10-PRODUCING LYMPHOCYTE COUNT | 2014 |
|
RU2575791C1 |
METHOD OF DIAGNOSTICS OF PREDISPOSITION TO PROGRESSION OF ATHEROSCLEROSIS OF CAROTID ARTERIES IN PERSONS WITH NORMOLIPIDEMIA ON CONTENT OF CD4 + T-LYMPHOCYTES IN PERIPHERAL BLOOD | 2016 |
|
RU2636238C2 |
METHOD FOR PREDICTION OF PROBABILITY OF DEVELOPMENT OF ATHEROSCLEROSIS IN MINERS WITH ANTHRACOSILICOSIS | 2015 |
|
RU2595086C1 |
METHOD FOR DETERMINING RISK OF CORONARY ARTERY ATHEROSCLEROSIS IN PATIENTS SUFFERING FROM DIABETES MELLITUS ACCOMPANIED BY CARDIOVASCULAR DISORDERS | 2013 |
|
RU2532521C1 |
METHOD FOR DETERMINING THE RISK OF RAPIDLY PROGRESSIVE ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE | 2022 |
|
RU2789003C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE, HAVING UNDERGONE PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770273C1 |
METHOD OF PREDICTING RISK OF DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES WITH PRIOR CORONARY ARTERY STENTING | 2015 |
|
RU2582291C1 |
METHOD FOR PREDICTING RISK OF ISCHEMIC STROKE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2020 |
|
RU2760854C1 |
METHOD FOR PREDICTION OF UNFAVORABLE CARDIOVASCULAR EVENTS WITHIN A YEAR AFTER CORONARY ARTERY BYPASS SURGERY | 2020 |
|
RU2731305C1 |
METHOD FOR DIAGNOSING THE DEVELOPMENT OF ISCHEMIC CARDIOMYOPATHY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2021 |
|
RU2765598C1 |
Authors
Dates
2024-02-15—Published
2023-06-09—Filed